Therapeutic approaches targeting cancer stem cells
- PMID: 30589025
- DOI: 10.4103/jcrt.JCRT_976_17
Therapeutic approaches targeting cancer stem cells
Abstract
Increasing studies have demonstrated that most tumors consisted a subpopulation of cells with stem cell properties, known as cancer stem cells (CSCs). Accumulating evidence indicated that CSCs may be critical driving force for several types of cancer. Hence, it was necessary to develop therapeutic approaches specifically targeting CSCs. In this review, first, the biological properties of CSCs were introduced, including the self-renewal and differentiation, high tumorigenesis and invasiveness, resistance to chemotherapy and radiotherapy, genetic and epigenetic variations. Meanwhile, CSCs-targeted therapeutic strategies were summarized, including targeting cell surface markers, signaling pathways, CSC niches, differentiation therapy, and drug resistance for CSCs. Furthermore, clinical trials on anti-CSCs therapies supported the efficacy of these therapies, as well as their combination with conventional chemotherapy and radiotherapy. CSCs could be significantly eradicated, eventually resulting in inhibited tumor growth, metastasis, and recurrence. Thus, selectively targeting CSCs with various agents may be a novel and promising therapeutic strategy against cancer.
Keywords: Anti-cancer stem cells therapy; biological properties; cancer stem cells.
Conflict of interest statement
None
Similar articles
-
Stem cell programs in cancer initiation, progression, and therapy resistance.Theranostics. 2020 Jul 9;10(19):8721-8743. doi: 10.7150/thno.41648. eCollection 2020. Theranostics. 2020. PMID: 32754274 Free PMC article. Review.
-
Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer.Curr Drug Targets. 2020;21(3):258-278. doi: 10.2174/1389450120666190821160730. Curr Drug Targets. 2020. PMID: 31433755 Review.
-
Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.Adv Cancer Res. 2016;131:159-91. doi: 10.1016/bs.acr.2016.04.003. Epub 2016 Jun 3. Adv Cancer Res. 2016. PMID: 27451127 Review.
-
Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.Pharmacol Ther. 2016 Feb;158:71-90. doi: 10.1016/j.pharmthera.2015.12.001. Epub 2015 Dec 17. Pharmacol Ther. 2016. PMID: 26706243 Review.
-
Recent Advances in Cancer Stem Cell Targeted Therapy.Crit Rev Oncog. 2019;24(1):1-20. doi: 10.1615/CritRevOncog.2018029574. Crit Rev Oncog. 2019. PMID: 31679215 Review.
Cited by
-
The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation.Cell Death Dis. 2022 Nov 16;13(11):961. doi: 10.1038/s41419-022-05424-1. Cell Death Dis. 2022. PMID: 36385098 Free PMC article.
-
LncRNA LINC01315 silencing modulates cancer stem cell properties and epithelial-to-mesenchymal transition in colorectal cancer via miR-484/DLK1 axis.Cell Cycle. 2022 Apr;21(8):851-873. doi: 10.1080/15384101.2022.2033415. Epub 2022 Feb 13. Cell Cycle. 2022. PMID: 35156543 Free PMC article.
-
Epigenetic Signaling of Cancer Stem Cells During Inflammation.Front Cell Dev Biol. 2021 Oct 15;9:772211. doi: 10.3389/fcell.2021.772211. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34722553 Free PMC article. Review.
-
CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancer.Br J Cancer. 2020 Sep;123(7):1131-1144. doi: 10.1038/s41416-020-0963-y. Epub 2020 Jul 1. Br J Cancer. 2020. PMID: 32606358 Free PMC article.
-
Cancer Stem Cell for Tumor Therapy.Cancers (Basel). 2021 Sep 26;13(19):4814. doi: 10.3390/cancers13194814. Cancers (Basel). 2021. PMID: 34638298 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources